PMDA — authorised 23 December 2022
- Marketing authorisation holder: Teikoku Seiyaku Co., Ltd.
- Status: approved
PMDA authorised Aricept on 23 December 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 December 2022.
Teikoku Seiyaku Co., Ltd. holds the Japanese marketing authorisation.